Research on colorectal cancer, ovarian cancer, and renal cancer showed that HSP90α could regulate EMT pathway, and downregulate its epithelial markers E-cadherin and Vimentin [33,34], resulting in tumor LNMs. The gene discussed is CDH1; the disease is neoplasm.